United Kingdom· GB-APID-15161911000001102
Mesna 1g/10ml solution for injection ampoules
A mesna product containing mesna, registered in United Kingdom by Baxter Healthcare Ltd. The same ATC class is registered in 4 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mesna is registered in 4 of 19 countries.
Countries holding a registration under ATC R05CB05 (mesna), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Mesna · ATC R05CB05
4 / 19 countries
- Germany
- Japan
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mesna
- Manufacturer
- Baxter Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- R05CB05
- ATC class
- Mesna
- Defined daily dose
- 1.2 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin05413760206929
- gtin5413760206929
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mesna in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesmesnaHikma Pharmaceuticals USA Inc.
- FinlandUromitexanParanova Oy
- SwedenUromitexan (med konserveringsmedel) 100 mg/ml Injektionsvätska, lösningBaxter Medical AB
- FranceMESNA EG 100 mg/ml, solution injectable pour perfusionEG LABO - LABORATOIRES EUROGENERICS
- NetherlandsUromitexan, omhulde tablet, 400 mgBaxter B.V.
- SpainMESNA ALTAN 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAltan Pharmaceuticals Sa
- GermanyMesna CellStadapharm Gmbh
- IrelandUromitexan 100mg/ml Solution for Injection or InfusionBaxter Holding B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Uromitexan
- Belgium · Uromitexan
- Bulgaria · Уромитексан
- Czechia · Uromitexan
- Germany · Mesna Cell, Mesna-Cell Stadapharm
- Denmark · Uromitexan, Uromitexan Cum Conservans
- Estonia · Uromitexan
- Spain · Mesna Altan, Mucofluid
- Finland · Uromitexan, Uromitexan Cum Conservans
- France · Mesna Eg, Uromitexan
- Greece · Uromitexan
- Croatia · Uromitexan
- Hungary · Uromitexan
- Ireland · Uromitexan
- Iceland · Uromitexan
- Italy · Uromitexan
- Lithuania · Uromitexan
- Luxembourg · Uromitexan
- Latvia · Uromitexan
- Malta · Uromitexan
- Netherlands · Uromitexan
- Norway · Uromitexan
- Poland · Uromitexan
- Portugal · Uromitexan
- Romania · Uromitexan
- Sweden · Uromitexan, Uromitexan (Med Konserveringsmedel)
- Slovakia · Uromitexan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ad13532-d14f-48cf-a6d1-b57ff1e603a6 GET /v1/drugs/1ad13532-d14f-48cf-a6d1-b57ff1e603a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "15161911000001102",
"desc": "Mesna 1g/10ml solution for injection ampoules (Baxter Healthcare Ltd)",
"form": "Solution for injection",
"vpid": "36041911000001101",
"source": "dmd",
"vtm_id": "776699001",
"strength": "100 mg",
"substance": "Mesna",
"ingredient": "Mesna",
"supplier_code": "2063601000001104"
}See everything about mesna.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.